KILITCH
Kilitch Drugs (India) Limited (KILITCH) Stock Analysis
Kilitch Drugs (India) Limited manufactures pharmaceutical formulations and APIs for regulated export markets. It supplies generics to emerging and developed markets with EU-GMP plants. The company focuses on anti-infectives and specialty therapies. It is a listed pharma exporter.
Healthcare › Drug Manufacturers - Specialty & Generic
₹241.60
+10.57% 1W | +41.90% 52W
Market Cap
845 CR
P/E Ratio
27.4
52W High
₹267.9
52W Low
₹117.2
Div. Yield
0%
Beta
0.3
50 DMA
₹191.6
200 DMA
₹172.7
Profit Margin
12.7%
Inst. Own.
0%
🚀 BREAKOUT
🚀 BREAKOUT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 36.56 | 41.20 | 31.79 | 44.82 | 33.45 | 47.47 | 56.17 | 61.23 | 43.14 | 48.92 | 53.81 | 89.60 | 44.88 |
| Expenses | 30.38 | 32.58 | 29.51 | 37.74 | 31.79 | 41.37 | 47.44 | 46.64 | 39.88 | 43.88 | 47.66 | 67.46 | 41.94 |
| Operating Profit | 6.18 | 8.62 | 2.28 | 7.08 | 1.66 | 6.10 | 8.73 | 14.59 | 3.26 | 5.04 | 6.15 | 22.14 | 2.94 |
| OPM % | 16.90% | 20.92% | 7.17% | 15.80% | 4.96% | 12.85% | 15.54% | 23.83% | 7.56% | 10.30% | 11.43% | 24.71% | 6.55% |
| Other Income | 0.56 | 0.49 | 2.96 | 0.47 | 2.57 | 5.16 | 1.73 | 1.70 | 2.56 | 6.66 | 1.53 | 0.49 | 2.90 |
| Interest | 1.50 | 1.51 | 1.60 | 1.32 | 1.73 | 0.31 | 1.40 | 1.60 | 1.53 | 1.44 | 1.15 | 1.44 | 0.88 |
| Depreciation | 0.71 | 0.82 | 0.81 | 0.93 | 0.85 | 0.61 | 0.81 | 0.85 | 0.84 | 0.86 | 0.94 | 0.98 | 1.09 |
| Profit before tax | 4.53 | 6.78 | 2.83 | 5.30 | 1.65 | 10.34 | 8.25 | 13.84 | 3.45 | 9.40 | 5.59 | 20.21 | 3.87 |
| Tax % | 32.67% | 24.93% | 38.16% | 30.57% | 93.33% | 16.73% | 32.00% | 26.23% | 34.49% | 14.47% | 22.90% | 26.37% | 48.84% |
| Net Profit | 3.06 | 5.09 | 1.74 | 3.68 | 0.11 | 8.61 | 5.61 | 10.22 | 2.27 | 8.04 | 4.31 | 14.88 | 1.96 |
| EPS in Rs | 0.99 | 1.35 | 0.83 | 1.03 | 0.38 | 2.46 | 1.70 | 2.97 | 0.87 | 2.34 | 1.27 | 4.15 | 0.83 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19 | 21 | 27 | 51 | 82 | 53 | 68 | 114 | 140 | 154 | 198 | 235 | 237 |
| Expenses | 21 | 25 | 28 | 45 | 75 | 53 | 63 | 104 | 122 | 130 | 167 | 198 | 201 |
| Operating Profit | -2 | -4 | -1 | 6 | 7 | 0 | 5 | 10 | 18 | 24 | 32 | 37 | 36 |
| OPM % | -9% | -19% | -2.0% | 11% | 9% | 0.8% | 8% | 9% | 13% | 16% | 16% | 16% | 15% |
| Other Income | 3 | 2 | 1 | 3 | 4 | 4 | 3 | 3 | 3 | 4 | 11 | 11 | 12 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 | 6 | 5 | 6 | 5 |
| Depreciation | 2 | 10 | 10 | 2 | 2 | 2 | 2 | 2 | 4 | 3 | 3 | 4 | 4 |
| Profit before tax | -1 | -12 | -9 | 6 | 9 | 2 | 5 | 10 | 12 | 19 | 34 | 39 | 39 |
| Tax % | -70% | -4% | -5% | 16% | 55% | 48% | 27% | 35% | 31% | 30% | 28% | 24% | |
| Net Profit | -0 | -11 | -9 | 5 | 4 | 1 | 4 | 6 | 8 | 14 | 25 | 30 | 29 |
| EPS in Rs | -0.10 | -3.89 | -3.09 | 1.72 | 1.15 | 0.25 | 1.09 | 2.17 | 3.08 | 4.17 | 7.63 | 8.63 | 8.59 |
| Dividend Payout % | 0% | 0% | 0% | 13% | 20% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 19.0% | 28.0% | 27.0% |
| Profit CAGR | 38.0% | 55.0% | 16.0% |
Shareholding Pattern
Promoters69.23%
Public30.77%
Promoters63.77%
Public36.22%
Promoters63.77%
Public36.23%
Promoters63.77%
Public36.22%
Promoters63.77%
FIIs0.12%
Public36.11%
Promoters68.24%
Public31.75%
Promoters69.23%
Public30.77%
Promoters69.23%
Public30.77%
Promoters63.77%
Public36.22%
Promoters63.77%
FIIs0.12%
Public36.11%
KILITCH
Holdings Analysis
Key strengths & risk signals
84
Overall
76
Fundamental
93
Technical
Risks (1)
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Strengths (4)
UNDERVALUED! PEG of 0.65 indicates stock is cheap relative to growth.
BULLISH TREND! 50-day average (191.6) is above 200-day average (172.7) - positive signal.
BREAKOUT! Stock has broken above resistance levels with momentum.
GOOD YEAR! Stock gained 41.9% in the last year.
Fundamental & Technical Analysis
84Overall
76Fundamental
93Technical
Fundamental Breakdown
Growth Quality
28/30
Revenue CAGR: 19.2% (VERY GOOD, 13/15). Profit CAGR: 42.4% (EXCELLENT, 15/15).
Profit Margin
5/10
DECENT EFFICIENCY! 12.7% profit margin - acceptable profitability.
PEG Valuation
10/10
UNDERVALUED! PEG of 0.65 indicates stock is cheap relative to growth.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 31.76% public ownership - moderate retail influence.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (191.6) is above 200-day average (172.7) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (241.6) is above both moving averages.
Trend Pattern
20/20
BREAKOUT! Stock has broken above resistance levels with momentum.
52W Performance
10/10
GOOD YEAR! Stock gained 41.9% in the last year.
Volume Sentiment
25/30
BULLISH SENTIMENT! In last 30 days: 19 up days, 11 down days. Avg volume on up days: 70,423 vs down days: 50,075. Ratio: 1.41x
RSI
3/5
BULLISH! RSI at 66.0 - positive momentum.
52W Range
5/5
STRONG! Trading at 82.5% of 52W range - near yearly highs.
Momentum
5/5
STRONG MOMENTUM! Price has grown across all timeframes - up 10.6% (1 week), 28.2% (1 month), 32.0% (3 months). Momentum is accelerating.
Beta
5/5
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KILITCH | ₹241.60 | 27.4 | 12.7% | 19.2% | 42.4% | +41.9% | 84 | BREAKOUT | -3.3% | -80.0% | +4.2% | -49.9% |
| ANUHPHR | ₹82.00 | 18.6 | 5.7% | 13.5% | 4.3% | +4.0% | 64 | BREAKDOWN | +37.3% | -2.6% | +3.9% | -4.1% |
| ZIMLAB | ₹150.50 | 183.5 | 0.9% | -2.5% | -37.9% | +105.9% | 57 | APPROACHING RESISTANCE | +110.5% | -208.1% | +31.2% | -10.5% |
| AMANTA | ₹187.40 | 45.1 | 5.0% | 3.3% | – | +54.5% | 61 | BREAKDOWN | -5.7% | -40.0% | +5.4% | -10.6% |
| BAFNAPH | ₹418.00 | 127.1 | 5.5% | 9.3% | -0.7% | +152.4% | 66 | BREAKOUT | -97.1% | -96.3% | -23.1% | -37.0% |
| THEMISMED | ₹108.60 | 25.1 | 12.1% | -0.4% | -72.8% | -16.1% | 53 | BREAKDOWN | -273.2% | +176.4% | -10.9% | +13.7% |
| WANBURY | ₹196.40 | 12.1 | 8.6% | 8.9% | – | -21.7% | 51 | APPROACHING SUPPORT | -76.3% | -85.3% | +1.5% | +0.6% |
| VALIANTLAB | ₹119.80 | 42.6 | 5.2% | -10.7% | – | +41.7% | 60 | BREAKDOWN | +1,072.2% | +1,072.2% | +146.4% | +25.3% |
Data from TradeAlone · Updated daily
No news tagged for KILITCH yet.
